Position
Parallel Advisors, LLC in BridgeBio Pharma, Inc.
Back to the book · All holders of BBIO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$305$76.49 → $74.26
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 137 | $10.5K | — | — | — | 0.0% |
| Q1 2026 | 894 | $66.4K | $74.26 | −$305 | $56.2K | 0.0% |